ERBB2 and breast carcinoma: Therefore, we examined the role of CIP2A in lapatinib-induced anti-cancer effects in ErbB2-overexpressing SKBR3 human breast cancer cells and 78617 cells, which are derived from spontaneous mammary tumors of MMTV-ErbB2 transgenic mice [31].